Correlation Between Duopharma Biotech and LPI Capital

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Duopharma Biotech and LPI Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Duopharma Biotech and LPI Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Duopharma Biotech Bhd and LPI Capital Bhd, you can compare the effects of market volatilities on Duopharma Biotech and LPI Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Duopharma Biotech with a short position of LPI Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Duopharma Biotech and LPI Capital.

Diversification Opportunities for Duopharma Biotech and LPI Capital

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between Duopharma and LPI is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Duopharma Biotech Bhd and LPI Capital Bhd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LPI Capital Bhd and Duopharma Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Duopharma Biotech Bhd are associated (or correlated) with LPI Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LPI Capital Bhd has no effect on the direction of Duopharma Biotech i.e., Duopharma Biotech and LPI Capital go up and down completely randomly.

Pair Corralation between Duopharma Biotech and LPI Capital

Assuming the 90 days trading horizon Duopharma Biotech Bhd is expected to under-perform the LPI Capital. In addition to that, Duopharma Biotech is 1.74 times more volatile than LPI Capital Bhd. It trades about -0.13 of its total potential returns per unit of risk. LPI Capital Bhd is currently generating about -0.09 per unit of volatility. If you would invest  1,342  in LPI Capital Bhd on September 1, 2024 and sell it today you would lose (18.00) from holding LPI Capital Bhd or give up 1.34% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

Duopharma Biotech Bhd  vs.  LPI Capital Bhd

 Performance 
       Timeline  
Duopharma Biotech Bhd 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Duopharma Biotech Bhd are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Duopharma Biotech is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.
LPI Capital Bhd 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in LPI Capital Bhd are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, LPI Capital is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Duopharma Biotech and LPI Capital Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Duopharma Biotech and LPI Capital

The main advantage of trading using opposite Duopharma Biotech and LPI Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Duopharma Biotech position performs unexpectedly, LPI Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LPI Capital will offset losses from the drop in LPI Capital's long position.
The idea behind Duopharma Biotech Bhd and LPI Capital Bhd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators